Difference between revisions of "LncRNAWiki:F"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''F11-AS1'' |F11-AS1 |N/A |F11 antisense RNA 1 |- |''FALEC...") |
|||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] '''F''' [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
+ | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''F11-AS1'' | |''F11-AS1'' | ||
Line 10: | Line 15: | ||
|N/A | |N/A | ||
|F11 antisense RNA 1 | |F11 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FALEC'' | |''FALEC'' | ||
|[[ENST00000416894.1]] | |[[ENST00000416894.1]] | ||
− | |LINC00568, long intergenic non-protein coding RNA 568, ENSG00000228126.1 | + | |"LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1" |
|focally amplified long non-coding RNA in epithelial cancer | |focally amplified long non-coding RNA in epithelial cancer | ||
+ | |ovarian cancer | ||
|- | |- | ||
|''FAM138A'' | |''FAM138A'' | ||
Line 20: | Line 27: | ||
|F379 | |F379 | ||
|family with sequence similarity 138 member A | |family with sequence similarity 138 member A | ||
+ | |_ | ||
|- | |- | ||
|''FAM138B'' | |''FAM138B'' | ||
Line 25: | Line 33: | ||
|F379 | |F379 | ||
|family with sequence similarity 138 member B | |family with sequence similarity 138 member B | ||
+ | |_ | ||
|- | |- | ||
|''FAM138C'' | |''FAM138C'' | ||
Line 30: | Line 39: | ||
|F379 | |F379 | ||
|family with sequence similarity 138 member C | |family with sequence similarity 138 member C | ||
+ | |_ | ||
|- | |- | ||
|''FAM138D'' | |''FAM138D'' | ||
Line 35: | Line 45: | ||
|F379 | |F379 | ||
|family with sequence similarity 138 member D | |family with sequence similarity 138 member D | ||
+ | |_ | ||
|- | |- | ||
|''FAM138E'' | |''FAM138E'' | ||
Line 40: | Line 51: | ||
|F379 | |F379 | ||
|family with sequence similarity 138 member E | |family with sequence similarity 138 member E | ||
+ | |_ | ||
|- | |- | ||
|''FAM138F'' | |''FAM138F'' | ||
Line 45: | Line 57: | ||
|F379 | |F379 | ||
|family with sequence similarity 138 member F | |family with sequence similarity 138 member F | ||
+ | |_ | ||
|- | |- | ||
|''FAM13A-AS1'' | |''FAM13A-AS1'' | ||
Line 50: | Line 63: | ||
|NCRNA00039 | |NCRNA00039 | ||
|FAM13A antisense RNA 1 | |FAM13A antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FAM201A'' | |''FAM201A'' | ||
Line 55: | Line 69: | ||
|N/A | |N/A | ||
|family with sequence similarity 201 member A | |family with sequence similarity 201 member A | ||
+ | |_ | ||
|- | |- | ||
|''FAM215A'' | |''FAM215A'' | ||
|[[FAM215A]] | |[[FAM215A]] | ||
− | |APR-2, LINC00530 | + | |"APR-2, LINC00530" |
|family with sequence similarity 215 member A (non-protein coding) | |family with sequence similarity 215 member A (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''FAM222A-AS1'' | |''FAM222A-AS1'' | ||
Line 65: | Line 81: | ||
|N/A | |N/A | ||
|FAM222A antisense RNA 1 | |FAM222A antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FAM226A'' | |''FAM226A'' | ||
Line 70: | Line 87: | ||
|MGC34827 | |MGC34827 | ||
|family with sequence similarity 226 member A (non-protein coding) | |family with sequence similarity 226 member A (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''FAM226B'' | |''FAM226B'' | ||
Line 75: | Line 93: | ||
|N/A | |N/A | ||
|family with sequence similarity 226 member B (non-protein coding) | |family with sequence similarity 226 member B (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''FAM27E3'' | |''FAM27E3'' | ||
Line 80: | Line 99: | ||
|MGC42630 | |MGC42630 | ||
|family with sequence similarity 27 member E3 | |family with sequence similarity 27 member E3 | ||
+ | |_ | ||
|- | |- | ||
|''FAM3D-AS1'' | |''FAM3D-AS1'' | ||
Line 85: | Line 105: | ||
|lnc-KCTD6-3 | |lnc-KCTD6-3 | ||
|FAM3D antisense RNA 1 | |FAM3D antisense RNA 1 | ||
+ | |head and neck squamous cell carcinoma | ||
|- | |- | ||
|''FAM41AY1'' | |''FAM41AY1'' | ||
|[[FAM41AY1]] | |[[FAM41AY1]] | ||
|N/A | |N/A | ||
− | |family with sequence similarity 41 member A, Y-linked 1 | + | |"family with sequence similarity 41 member A, Y-linked 1" |
+ | |_ | ||
|- | |- | ||
|''FAM41C'' | |''FAM41C'' | ||
Line 95: | Line 117: | ||
|N/A | |N/A | ||
|family with sequence similarity 41 member C | |family with sequence similarity 41 member C | ||
+ | |_ | ||
|- | |- | ||
|''FAM66C'' | |''FAM66C'' | ||
Line 100: | Line 123: | ||
|N/A | |N/A | ||
|family with sequence similarity 66 member C | |family with sequence similarity 66 member C | ||
+ | |_ | ||
|- | |- | ||
|''FAM74A3'' | |''FAM74A3'' | ||
Line 105: | Line 129: | ||
|OTTHUMG00000067149 | |OTTHUMG00000067149 | ||
|family with sequence similarity 74 member A3 | |family with sequence similarity 74 member A3 | ||
+ | |_ | ||
|- | |- | ||
|''FAM83H-AS1'' | |''FAM83H-AS1'' | ||
Line 110: | Line 135: | ||
|onco-lncRNA-3 | |onco-lncRNA-3 | ||
|FAM83H antisense RNA 1 (head to head) | |FAM83H antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''FAM87A'' | |''FAM87A'' | ||
Line 115: | Line 141: | ||
|N/A | |N/A | ||
|family with sequence similarity 87 member A | |family with sequence similarity 87 member A | ||
+ | |_ | ||
|- | |- | ||
|''FAS-AS'' | |''FAS-AS'' | ||
|[[NONHSAT015489]] | |[[NONHSAT015489]] | ||
− | |SAF, ENSG00000026103 | + | |"SAF, ENSG00000026103" |
|FAS antisense RNA 1 | |FAS antisense RNA 1 | ||
+ | |B-cell lymphoma | ||
|- | |- | ||
|''FAS-AS1'' | |''FAS-AS1'' | ||
Line 125: | Line 153: | ||
|SAF | |SAF | ||
|FAS antisense RNA 1 | |FAS antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FENDRR'' | |''FENDRR'' | ||
|[[FENDRR]] | |[[FENDRR]] | ||
|FOXF1 adjacent non-coding developmental regulatory RNA | |FOXF1 adjacent non-coding developmental regulatory RNA | ||
− | |lincFOXF1, onco-lncRNA-21 | + | |"lincFOXF1, onco-lncRNA-21" |
+ | |Heart Failure | ||
|- | |- | ||
|''FGF10-AS1'' | |''FGF10-AS1'' | ||
Line 135: | Line 165: | ||
|RP11-473L15.2 | |RP11-473L15.2 | ||
|FGF10 antisense RNA 1 | |FGF10 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FIRRE'' | |''FIRRE'' | ||
Line 140: | Line 171: | ||
|firre intergenic repeating RNA element | |firre intergenic repeating RNA element | ||
|LINC01200 | |LINC01200 | ||
+ | |_ | ||
|- | |- | ||
|''FLG-AS1'' | |''FLG-AS1'' | ||
Line 145: | Line 177: | ||
|N/A | |N/A | ||
|FLG antisense RNA 1 | |FLG antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FLVCR1-AS1'' | |''FLVCR1-AS1'' | ||
Line 150: | Line 183: | ||
|LQK1 | |LQK1 | ||
|FLVCR1 antisense RNA 1 (head to head) | |FLVCR1 antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''FMR1-AS1'' | |''FMR1-AS1'' | ||
|[[FMR1-AS1]] | |[[FMR1-AS1]] | ||
− | |ASFMR1, FMR4 | + | |"ASFMR1, FMR4" |
|FMR1 antisense RNA 1 | |FMR1 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''FOXC2-AS1'' | |''FOXC2-AS1'' | ||
Line 160: | Line 195: | ||
|ODRUL | |ODRUL | ||
|FOXC2 antisense RNA 1 | |FOXC2 antisense RNA 1 | ||
+ | |osteosarcoma | ||
|- | |- | ||
|''FOXCUT'' | |''FOXCUT'' | ||
Line 165: | Line 201: | ||
|TCONS_00011636 | |TCONS_00011636 | ||
|FOXC1 upstream transcript (non-protein coding) | |FOXC1 upstream transcript (non-protein coding) | ||
+ | |esophageal squamous cell carcinoma, basal-like breast cancer | ||
|- | |- | ||
|''FOXG1-AS1'' | |''FOXG1-AS1'' | ||
Line 170: | Line 207: | ||
|FOXG1-AS | |FOXG1-AS | ||
|FOXG1 antisense RNA 1 (head to head) | |FOXG1 antisense RNA 1 (head to head) | ||
+ | |autism spectrum disorders | ||
|- | |- | ||
|''FRGCA'' | |''FRGCA'' | ||
|[[FRGCA]] | |[[FRGCA]] | ||
|LncRNA-AP001631.9 | |LncRNA-AP001631.9 | ||
− | |FOXM1-regulated, gastric cancer associated | + | |"FOXM1-regulated, gastric cancer associated" |
+ | |gastric cancer | ||
|- | |- | ||
|''FTX'' | |''FTX'' | ||
|[[ENST00000602812.1]] | |[[ENST00000602812.1]] | ||
− | |LINC00182,FLJ33139 | + | |"LINC00182,FLJ33139" |
− | |FTX transcript, XIST regulator (non-protein coding) | + | |"FTX transcript, XIST regulator (non-protein coding)" |
+ | |epatocellular carcinoma, colorectal cancer | ||
|} | |} |
Revision as of 10:16, 30 June 2016
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
F11-AS1 | F11-AS1 | N/A | F11 antisense RNA 1 | _ |
FALEC | ENST00000416894.1 | "LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1" | focally amplified long non-coding RNA in epithelial cancer | ovarian cancer |
FAM138A | FAM138A | F379 | family with sequence similarity 138 member A | _ |
FAM138B | FAM138B | F379 | family with sequence similarity 138 member B | _ |
FAM138C | FAM138C | F379 | family with sequence similarity 138 member C | _ |
FAM138D | FAM138D | F379 | family with sequence similarity 138 member D | _ |
FAM138E | FAM138E | F379 | family with sequence similarity 138 member E | _ |
FAM138F | FAM138F | F379 | family with sequence similarity 138 member F | _ |
FAM13A-AS1 | FAM13A-AS1 | NCRNA00039 | FAM13A antisense RNA 1 | _ |
FAM201A | FAM201A | N/A | family with sequence similarity 201 member A | _ |
FAM215A | FAM215A | "APR-2, LINC00530" | family with sequence similarity 215 member A (non-protein coding) | _ |
FAM222A-AS1 | FAM222A-AS1 | N/A | FAM222A antisense RNA 1 | _ |
FAM226A | FAM226A | MGC34827 | family with sequence similarity 226 member A (non-protein coding) | _ |
FAM226B | FAM226B | N/A | family with sequence similarity 226 member B (non-protein coding) | _ |
FAM27E3 | FAM27E3 | MGC42630 | family with sequence similarity 27 member E3 | _ |
FAM3D-AS1 | FAM3D-AS1 | lnc-KCTD6-3 | FAM3D antisense RNA 1 | head and neck squamous cell carcinoma |
FAM41AY1 | FAM41AY1 | N/A | "family with sequence similarity 41 member A, Y-linked 1" | _ |
FAM41C | FAM41C | N/A | family with sequence similarity 41 member C | _ |
FAM66C | FAM66C | N/A | family with sequence similarity 66 member C | _ |
FAM74A3 | FAM74A3 | OTTHUMG00000067149 | family with sequence similarity 74 member A3 | _ |
FAM83H-AS1 | FAM83H-AS1 | onco-lncRNA-3 | FAM83H antisense RNA 1 (head to head) | _ |
FAM87A | FAM87A | N/A | family with sequence similarity 87 member A | _ |
FAS-AS | NONHSAT015489 | "SAF, ENSG00000026103" | FAS antisense RNA 1 | B-cell lymphoma |
FAS-AS1 | FAS-AS1 | SAF | FAS antisense RNA 1 | _ |
FENDRR | FENDRR | FOXF1 adjacent non-coding developmental regulatory RNA | "lincFOXF1, onco-lncRNA-21" | Heart Failure |
FGF10-AS1 | FGF10-AS1 | RP11-473L15.2 | FGF10 antisense RNA 1 | _ |
FIRRE | ENST00000427391.1 | firre intergenic repeating RNA element | LINC01200 | _ |
FLG-AS1 | FLG-AS1 | N/A | FLG antisense RNA 1 | _ |
FLVCR1-AS1 | FLVCR1-AS1 | LQK1 | FLVCR1 antisense RNA 1 (head to head) | _ |
FMR1-AS1 | FMR1-AS1 | "ASFMR1, FMR4" | FMR1 antisense RNA 1 | _ |
FOXC2-AS1 | FOXC2-AS1 | ODRUL | FOXC2 antisense RNA 1 | osteosarcoma |
FOXCUT | Lnc-FOXC1-1:1,NONHSAT106529 | TCONS_00011636 | FOXC1 upstream transcript (non-protein coding) | esophageal squamous cell carcinoma, basal-like breast cancer |
FOXG1-AS1 | FOXG1-AS1 | FOXG1-AS | FOXG1 antisense RNA 1 (head to head) | autism spectrum disorders |
FRGCA | FRGCA | LncRNA-AP001631.9 | "FOXM1-regulated, gastric cancer associated" | gastric cancer |
FTX | ENST00000602812.1 | "LINC00182,FLJ33139" | "FTX transcript, XIST regulator (non-protein coding)" | epatocellular carcinoma, colorectal cancer |